MyAverix Finance
F · Healthcare
SILENCE THERAP. SP.ADR/1 (XRP2)
Biotechnology
SILENCE THERAP. SP.ADR/1 (XRP2) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for XRP2
SILENCE THERAP. SP.ADR/1 (XRP2) — FAQ
What is XRP2's P/E ratio?
The price-to-earnings (P/E) ratio for SILENCE THERAP. SP.ADR/1 (XRP2) is 25.00 (data as of 2026-05-21).
Does SILENCE THERAP. SP.ADR/1 pay a dividend?
Dividend yield is not available in the current snapshot for SILENCE THERAP. SP.ADR/1 (XRP2). Check the MyAverix Finance app for the latest dividend data.
What sector is SILENCE THERAP. SP.ADR/1 in?
SILENCE THERAP. SP.ADR/1 (XRP2) is classified in the Healthcare sector (Biotechnology industry).
What exchange is XRP2 listed on?
XRP2 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.